Luigi Alfano

7PUBLICATIONS
41CO-AUTHORS
Molecular targetsRadiation therapyExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 28, 2026
Machine Learning-Based Virtual Screening for the Identification of Novel CDK-9 Inhibitors.

Lisa Piazza, Clarissa Poles, Giulia Bononi

|Sep 27, 2025
Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines.

Margherita D'Angelo, Annamaria Medugno, Maria Cuomo

|Jan 08, 2025
Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell Death.

Giulio Mazzarotti, Maria Cuomo, Maria Carmen Ragosta

|Mar 03, 2024
CDK9-55 guides the anaphase-promoting complex/cyclosome (APC/C) in choosing the DNA repair pathway choice.

Luigi Alfano, Carmelina Antonella Iannuzzi, Daniela Barone

|Dec 17, 2020
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.

Rita Lombardi, Maura Sonego, Biagio Pucci

|Aug 09, 2019
Genomic analysis reveals association of specific SNPs with athletic performance and susceptibility to injuries in professional soccer players.

Raffaele La Montagna, Raffaele Canonico, Luigi Alfano

Pageof 2